NCT02442752 Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months Status WITHDRAWN Phase PHASE1
NCT02430870 TAK-648 Multiple-Rising Dose Study in Healthy Japanese Participants and Non-Japanese Participants With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE1
NCT02427958 A Study to Assess the Safety and Efficacy of Leuprorelin in Central Precocious Puberty in Chinese Participants Status COMPLETED Phase PHASE4
NCT02425111 Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease Status COMPLETED Phase PHASE3
NCT02425098 Safety and Immunogenicity With Two Different Serotype 2 Potencies of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Adults in Singapore Status COMPLETED Phase PHASE2
NCT02415712 Specified Drug-use Survey of Fomepizole Intravenous Infusion (All-case Surveillance) Status COMPLETED Phase N/A
NCT02413255 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Single- and Multiple-Doses of TAK-020 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02410499 Efficacy and Safety of Weekly Subcutaneous MLN1202 in Improving Diabetic Nephropathy in Participants With Macroalbuminuria Status WITHDRAWN Phase PHASE2
NCT02400775 A Study to Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia. Status WITHDRAWN Phase PHASE4
NCT02396147 Bioavailability and Effect of Food on TAK-385 Tablet Formulations in Healthy Participants Status COMPLETED Phase PHASE1
NCT02394834 An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02394795 Panitumumab and RAS, Diagnostically-useful Gene Mutation for mCRC Status COMPLETED Phase PHASE3
NCT02393378 Namilumab vs Adalimumab in Participants With Moderate to Severe Early Rheumatoid Arthritis Inadequately Responding to Methotrexate Status TERMINATED Phase PHASE2
NCT02389881 Safety, Tolerability, and Pharmacokinetics of Multiple-Dose TAK-058 in Healthy Participants Status COMPLETED Phase PHASE1
NCT02389816 A Phase 3 Study of Lu AA21004 in Patients With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT02388971 Proof of Mechanism Study of MLN1202 on Atherosclerotic Inflammation in Participants With Stable Atherosclerotic Cardiovascular Disease Status WITHDRAWN Phase PHASE2
NCT02388737 Efficacy and Safety of Vonoprazan Compared to Lansoprazole in the Maintenance Treatment of Erosive Esophagitis Status COMPLETED Phase PHASE3
NCT02388724 Efficacy and Safety of Oral Once-Daily Vonoprazan (TAK-438) in Participants With Erosive Esophagitis Status COMPLETED Phase PHASE3